Suppr超能文献

相似文献

1
Rewriting the prognosis of multiple sclerosis in Brazil: a 25-year perspective on evolving diagnostic criteria.
Arq Neuropsiquiatr. 2025 Jun;83(6):1-2. doi: 10.1055/s-0045-1809937. Epub 2025 Jul 2.
2
The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort.
Arq Neuropsiquiatr. 2025 Jun;83(6):1-9. doi: 10.1055/s-0045-1809662. Epub 2025 Jun 25.
3
Overall prognosis of preschool autism spectrum disorder diagnoses.
Cochrane Database Syst Rev. 2022 Sep 28;9(9):CD012749. doi: 10.1002/14651858.CD012749.pub2.
4
Azathioprine for people with multiple sclerosis.
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
5
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
6
Prevalence of multiple sclerosis in Brazil: An updated systematic review with meta-analysis.
Clin Neurol Neurosurg. 2025 Feb;249:108741. doi: 10.1016/j.clineuro.2025.108741. Epub 2025 Jan 13.
8
Longitudinally extensive transverse myelitis: Impact on functional prognosis and mortality in a 10-year follow-up cohort.
Mult Scler Relat Disord. 2025 Feb;94:106279. doi: 10.1016/j.msard.2025.106279. Epub 2025 Jan 20.
9
Artificial intelligence in the diagnosis of multiple sclerosis: A systematic review.
Mult Scler Relat Disord. 2022 Mar;59:103673. doi: 10.1016/j.msard.2022.103673. Epub 2022 Feb 7.
10
Ocrelizumab for multiple sclerosis.
Cochrane Database Syst Rev. 2022 May 18;5(5):CD013247. doi: 10.1002/14651858.CD013247.pub2.

本文引用的文献

1
The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort.
Arq Neuropsiquiatr. 2025 Jun;83(6):1-9. doi: 10.1055/s-0045-1809662. Epub 2025 Jun 25.
2
The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil.
Arq Neuropsiquiatr. 2024 Jan;82(1):1-2. doi: 10.1055/s-0044-1779036. Epub 2024 Feb 5.
4
Real-world application of the 2022 diagnostic criteria for first-ever episode of optic neuritis.
J Neuroimmunol. 2023 Aug 15;381:578140. doi: 10.1016/j.jneuroim.2023.578140. Epub 2023 Jun 20.
6
Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil.
Mult Scler Relat Disord. 2023 Feb;70:104488. doi: 10.1016/j.msard.2022.104488. Epub 2022 Dec 23.
7
Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center's approach.
Arq Neuropsiquiatr. 2022 Oct;80(10):1057-1066. doi: 10.1055/s-0042-1754348. Epub 2022 Oct 4.
8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验